iShares Neuroscience and Healthcare ETF IBRN

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IBRN

Will IBRN outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Neuroscience and Healthcare ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBRN

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 44.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Praxis Precision Medicines Inc Ordinary Shares

5.45 426,308
Healthcare

Dianthus Therapeutics Inc

5.12 400,259
Healthcare

ACADIA Pharmaceuticals Inc

4.82 376,461
Healthcare

Xenon Pharmaceuticals Inc

4.67 365,148
Healthcare

Scholar Rock Holding Corp

4.51 352,212
Healthcare

Arrowhead Pharmaceuticals Inc

4.40 344,157
Healthcare

Alkermes PLC

4.35 339,722
Healthcare

Biogen Inc

4.06 317,028
Healthcare

PTC Therapeutics Inc

3.82 298,316
Healthcare

Denali Therapeutics Inc

3.71 289,550
Healthcare

Sponsor Center